Unknown OBSERVATIONAL NCT03306134

The Effect of Beta-blockers in Substance P Levels and the Swallowing Function (BETASP)

Sponsor: Hospital de Mataró

Conditions Beta Blockers Substance P Swallowing Disorder

Interventions Dysphagia

Updated 7 times since 2017 Last updated: Feb 21, 2018 Started: Jun 5, 2017 Primary completion: Nov 25, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03306134, this observational or N/A phase trial focuses on Beta Blockers and Substance P and remains ongoing. Sponsored by Hospital de Mataró, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Mar 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Mar 2020 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Mataró

Data source: Hospital de Mataró

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mataró, Spain